# Study of ONO-1101 in Patients Scheduled for Coronary Angiography

> **NCT00560209** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 183 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** ONO-1101
- **DRUG:** ONO-1101
- **DRUG:** ONO-1101

## Key facts

- **NCT ID:** NCT00560209
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00560209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00560209, "Study of ONO-1101 in Patients Scheduled for Coronary Angiography". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00560209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*